Manja Koch1, Sarah A Aroner1,2, Annette L Fitzpatrick3,4,5, W T Longstreth6,7, Jeremy D Furtado1, Kenneth J Mukamal1,8, Majken K Jensen1,9. 1. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA (M.K., S.A.A., J.D.F., K.J.M., M.K.J.). 2. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (S.A.A.). 3. Departments of Family Medicine (A.L.F.), University of Washington, Seattle. 4. Epidemiology (A.L.F.), University of Washington, Seattle. 5. Global Health (A.L.F.), University of Washington, Seattle. 6. Neurology (W.T.L.), University of Washington, Seattle. 7. Epidemiology (W.T.L.), University of Washington, Seattle. 8. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA (K.J.M.). 9. Department of Public Health, Section of Epidemiology, University of Copenhagen, Denmark (M.K.J.).
Abstract
BACKGROUND: Whether HDL (high-density lipoprotein) is associated with risk of vascular brain injury is unclear. HDL is comprised of many apo (apolipoprotein) species, creating distinct subtypes of HDL. METHODS: We utilized sandwich ELISA to determine HDL subspecies from plasma collected in 1998/1999 from 2001 CHS (Cardiovascular Health Study) participants (mean age, 80 years). RESULTS: In cross-sectional analyses, participants with higher apoA1 in plasma and lower apoE in HDL were less likely to have prevalent covert magnetic resonance imaging-defined infarcts: odds ratio for apoA1 Q4 versus Q1, 0.68 (95% CI, 0.50-0.93), and odds ratio for apoE Q4 versus Q1, 1.36 (95% CI, 1.01-1.84). Similarly, apoA1 in the subspecies of HDL that lacked apoC3, apoJ, or apoE was inversely related to covert infarcts, and apoE in the subspecies of HDL that lacked apoC3 or apoJ was directly related to covert infarcts in prospective analyses. In contrast, the concentrations of apoA1 and apoE in the complementary subspecies of HDL that contained these apos were unrelated to covert infarcts. Patterns of associations between incident overt ischemic stroke and apoA1, apoE, and apoA1 and apoE in subspecies of HDL were similar to those observed for covert infarcts but less pronounced. CONCLUSIONS: This study highlights HDL subspecies defined by apo content as relevant biomarkers of covert and overt vascular brain injury.
BACKGROUND: Whether HDL (high-density lipoprotein) is associated with risk of vascular brain injury is unclear. HDL is comprised of many apo (apolipoprotein) species, creating distinct subtypes of HDL. METHODS: We utilized sandwich ELISA to determine HDL subspecies from plasma collected in 1998/1999 from 2001 CHS (Cardiovascular Health Study) participants (mean age, 80 years). RESULTS: In cross-sectional analyses, participants with higher apoA1 in plasma and lower apoE in HDL were less likely to have prevalent covert magnetic resonance imaging-defined infarcts: odds ratio for apoA1 Q4 versus Q1, 0.68 (95% CI, 0.50-0.93), and odds ratio for apoE Q4 versus Q1, 1.36 (95% CI, 1.01-1.84). Similarly, apoA1 in the subspecies of HDL that lacked apoC3, apoJ, or apoE was inversely related to covert infarcts, and apoE in the subspecies of HDL that lacked apoC3 or apoJ was directly related to covert infarcts in prospective analyses. In contrast, the concentrations of apoA1 and apoE in the complementary subspecies of HDL that contained these apos were unrelated to covert infarcts. Patterns of associations between incident overt ischemic stroke and apoA1, apoE, and apoA1 and apoE in subspecies of HDL were similar to those observed for covert infarcts but less pronounced. CONCLUSIONS: This study highlights HDL subspecies defined by apo content as relevant biomarkers of covert and overt vascular brain injury.
Authors: Jose Ruiz; Diana Kouiavskaia; Molly Migliorini; Susan Robinson; Evgueni L Saenko; Natalia Gorlatova; Donghua Li; Daniel Lawrence; Bradley T Hyman; Karl H Weisgraber; Dudley K Strickland Journal: J Lipid Res Date: 2005-05-01 Impact factor: 5.922
Authors: Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh Journal: JAMA Date: 2009-11-11 Impact factor: 56.272
Authors: Peter van Vliet; Simon P Mooijaart; Anton J M de Craen; Patrick C N Rensen; Diana van Heemst; Rudi G J Westendorp Journal: Ann N Y Acad Sci Date: 2007-04 Impact factor: 5.691